Tenet Healthcare Corp

Tenet Healthcare Corp(THC)の株式分析

$267.250

-7.643 (-2.86%)終値時点

Loading chart…
高値
278.390
始値
276.960
出来高加重平均価格
270.43
出来高
827.87K
時価総額
13.51B
安値
265.650
売買代金
223.88M
EV/EBITDA(TTM)
6.54

Tenet Healthcare Corporation is a diversified healthcare services company. The Company's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment consists of its acute care and specialty hospitals, imaging centers, ancillary outpatient facilities, micro-hospitals and physician practices. The Company's subsidiaries operate approximately 50 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 132 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency department and micro hospitals. It also provides revenue cycle management and value based care services. Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 533 ambulatory surgery centers, and 26 surgical hospitals in 37 states. It also operates a Global Business Center in the Philippines.

www.tenethealth.com

AI分析 of Tenet Healthcare Corp (THC)

買い

Tenet Healthcare Corp is a good buy right now due to its strong financial performance, with a gross margin of 78.70% and a year-to-date price increase of 33.99%. The stock is currently priced at $267.25, which is below the median analyst target of $284, suggesting potential for growth. However, the main risk is the forward P/E ratio of 12.53, which indicates that the stock may be overvalued if earnings do not meet expectations.

アナリスト評価(16)

-9.12% 下落余地
中立
4 買い
12 中立
0 売り
現在: 267.25
安値
229.00
平均
242.89
高値
260.00

BMO Capital

2026-09-22

目標株価

$265

Market Perform

BofA

2026-08-10

目標株価

$295

買い

Mizuho

2026-08-10

目標株価

$290

アウトパフォーム

Wells Fargo

2026-08-03

目標株価

$281

オーバーウェイト

Goldman Sachs

2026-07-28

目標株価

$305

買い

バリュエーション指標

Tenet Healthcare Corp(THC)の現在の予想PERは12.53で、5年平均は11.90です。

予想PER

適正
5年平均 P/E
11.90
現在のP/E
12.53
割高
13.93
割安
9.87

予想EV/EBITDA

適正
5年平均 EV/EBITDA
6.93
現在のEV/EBITDA
6.54
割高
7.53
割安
6.32

予想PSR

割高
5年平均 P/S
0.54
現在のP/S
0.96
割高
0.75
割安
0.33

Alphio AI による THC の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%THC

$152.71

シナリオ価格

基

基本

基本 · 50%THC

$138.03

シナリオ価格

弱

弱気

弱気 · 25%THC

$113.61

シナリオ価格

THC を保有するクジラ

C

Crake Asset Management LLP

+ を保有THC

+5.63%

3か月リターン

M

Meridiem Capital Partners LP

+ を保有THC

+3.28%

3か月リターン

B

BW Gestao de Investimentos Ltda.

+ を保有THC

+2.45%

3か月リターン

B

Boston Partners Global Investors, Inc.

+ を保有THC

+2.19%

3か月リターン

P

Pale Fire Capital SE

+ を保有THC

-2.45%

3か月リターン

M

Moore Capital Management, LP

+ を保有THC

-3.72%

3か月リターン

THC のよくある質問 — Alphio AI が回答

Tenet Healthcare Corporation is a diversified healthcare services company. The Company's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment consists of its acute care and specialty hospitals, imaging centers, ancillary outpatient facilities, micro-hospitals and physician practices. The Company's subsidiaries operate approximately 50 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 132 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency department and micro hospitals. It also provides revenue cycle management and value based care services. Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 533 ambulatory surgery centers, and 26 surgical hospitals in 37 states. It also operates a Global Business Center in the Philippines. It operates in the Healthcare sector (SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC industry).

Tenet Healthcare Corp is a good buy right now due to its strong financial performance, with a gross margin of 78.70% and a year-to-date price increase of 33.99%. The stock is currently priced at $267.25, which is below the median analyst target of $284, suggesting potential for growth. However, the main risk is the forward P/E ratio of 12.53, which indicates that the stock may be overvalued if earnings do not meet expectations.

16 analysts cover THC: 4 rate it Buy, 12 Hold and 0 Sell. The average price target is 242.89.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める